Zoekresultaten - 100 results
Speeding up drug susceptibility testing in Mycobacterium tuberculosis using RNA biomarkers
Publication Type: Peer reviewed scientific article Authors: Amandine Sury*; Margo Maex; Baulard, Alain; Bhattacharyya, Roby P.; Stéphanie Depickère; Hung, Deborah T.; Cos, Paul; Sayes, Fadel; Frigui, Wafa; Brosch, Roland; Vanessa Mathys; Streicher, Elizab ...
Antimicrobial resistance in ESBL and indicator E. coli, Campylobacter spp.,Salmonella spp., methicillin-resistant Staphylococcus aureus (MRSA) and Enterococcus faecalis and faecium isolated from food and food-producing animals (primary production) in 2023
EUCAST (European Committee on Antimicrobial Susceptibility Testing). In 2023, the European Commission Implementing Decision 2020/1729 of the 17th of November 2020 was applicable for the determination of ...
Azithromycin resistance in Escherichia coli and Salmonella from food-producing animals and meat in Europe.
Chemother, Volume 79, Issue 7 (2024) Keywords: Animals Anti-Bacterial Agents Azithromycin Drug Resistance, Bacterial Epidemiological Monitoring Escherichia coli Escherichia coli Infections Europe Genes, ...
Multicenter interlaboratory study of routine systems for the susceptibility testing of temocillin using a challenge panel of multidrug-resistant strains.
method used as gold standard. Methods’ reproducibility was assessed by testing 3 reference strains in triplicate. A total of 702 organism-drug results were obtained against 33 TMO-susceptible and 14 ...
Persistence of the Staphylococcus aureus epidemic European fusidic acid-resistant impetigo clone (EEFIC) in Belgium.
from CO- SSTI each month. Isolates were tested for antimicrobial susceptibility to oxacillin, mupirocin and fusidic acid. Resistant isolates were also spa typed and tested for the presence of the genes ...
Towards clinical breakpoints for non-tuberculous mycobacteria- Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution.
their importance for establishing antimicrobial susceptibility testing (AST) breakpoints. METHODS: We gathered MIC distributions for drugs used against the Mycobacterium avium complex (MAC) and ...
The 2021 WHO catalogue of complex mutations associated with drug resistance: A genotypic analysis.
Tuberculosis Abstract: Background: Molecular diagnostics are considered the most promising route to achieving rapid, universal drug susceptibility testing for complex (MTBC). We aimed to generate a WHO endorsed ...
Retrospective evaluation of routine whole genome sequencing of Mycobacterium tuberculosis at the Belgian National Reference Center, 2019.
MTB strains analyzed in 2019 (n = 306). RESULTS: In all cases, the WGS-based procedure was able to identify correctly the MTB species. Compared to MGIT drug susceptibility testing (DST), the sensitivity ...
First detection of a plasmid-encoded New-Delhi metallo-beta-lactamase-1 (NDM-1) producing Acinetobacter baumannii using whole genome sequencing, isolated in a clinical setting in Benin.
extensively-drug resistant A. baumannii strain solely susceptible to amikacin, colistin and ciprofloxacin, and resistant to several other antibiotics including ceftazidime, imipenem, meropenem, gentamicin, ...
Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs.
J (2020) Abstract: Conventional molecular tests for detecting complex (MTBC) drug resistance on clinical samples cover a limited set of mutations. Whole genome sequencing (WGS) typically requires culture. ...